Aarkstore.com || Cataract – Pipeline Review, H1 2012 || Market Research

1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Cataract – Pipeline Review, H1 2012
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Markets Direct’s, Cataract - Pipeline Review, H1 2012, provides an overview
of the Cataract therapeutic pipeline. This report provides information on the
therapeutic development for Cataract, complete with latest updates, and special
features on late-stage and discontinued projects. It also reviews key players
involved in the therapeutic development for Cataract. Cataract - Pipeline Review, H1
2012 is built using data and information sourced from Global Markets Direct’s
proprietary databases, Company/University websites, SEC filings, investor
presentations and featured press releases from company/university sites and
industry-specific third party sources, put together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Cataract.
- A review of the Cataract products under development by companies and
universities/research institutes based on information derived from company and
industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined
therapeutics.

2. Table of contents:
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Cataract Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Cataract 7
Cataract Therapeutics under Development by Companies 9
Mid Clinical Stage Products 10
Comparative Analysis 10
Pre-Clinical Stage Products 11
Comparative Analysis 11
Cataract Therapeutics – Products under Development by Companies 12
Companies Involved in Cataract Therapeutics Development 13
InSite Vision Incorporated 13
R-Tech Ueno, Ltd. 14
NovaLead Pharma Pvt. Ltd. 15
Omeros Corporation 16
ESBATech AG 17
Cataract – Therapeutics Assessment 18
Assessment by Monotherapy Products 18
Assessment by Route of Administration 19
Assessment by Molecule Type 21
Drug Profiles 23
BromSite - Drug Profile 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
ESBA 105 - Drug Profile 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Bendavia - Drug Profile 26

3. Product Description 26
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1
2012&PubId=&pagenum=1
Hereditary Angioedema (HAE) – Pipeline Review, H1 2012
Cataract – Pipeline Review, H1 2012
Neurofibromatoses – Pipeline Review, H1 2012
Viral Conjunctivitis – Pipeline Review, H1 2012
Fistula – Pipeline Review, H1 2012
Onchocerciasis (River Blindness) – Pipeline Review, H1 2012
Seborrhea – Pipeline Review, H1 2012
Cerebral Palsy – Pipeline Review, H1 2012
Hemolytic Disease In Newborns – Pipeline Review, H1 2012

4. Panic Disorders – Pipeline Review, H1 2012
4SC AG – Product Pipeline Review – 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com